• Events
  • 3rd Amyloidosis Symposium: “New Discoveries & Evolving Approaches”

3rd Amyloidosis Symposium: “New Discoveries & Evolving Approaches”

Date & Time

Saturday, August 16, 2025, 8:00 a.m.-3:00 p.m.

Category

Education

Location

RWJMS Clinical Academic Building (CAB). Room 1302, 125 Paterson Street, New Brunswick, NJ 08901

Contact

Andrea Bernard

Information

Registration:

Registration is complimentary! Click to register. Registration deadline: Aug 13, 2025

 

Confirmation:

Upon registration, participants will receive an email confirmation. Additional details will be provided as the symposium date nears.

Photo Flyer for the 3rd Amyloidosis Symposium
Course Overview

This symposium aims to increase awareness of amyloidosis as well as focus on its cardiac and neuropathic manifestations. Experts will lead discussions on both non-invasive and invasive diagnostic techniques for cardiac amyloidosis, highlight key challenges and pitfalls regarding false readings and discuss how to improve diagnostic accuracy. Participants will have the opportunity to explore the complexities of amyloid cardiomyopathy and amyloid polyneuropathy, gain insights in how they are presented clinically and how they impact patient care. Exploring current emerging treatment strategies and empowering clinicians to develop evidence-based individualized treatment plans will also be discussed.

Learning Objectives

1. Describe the pathophysiology, clinical presentation, and diagnostic approach to amyloidosis, with a focus on amyloid cardiomyopathy and amyloid polyneuropathy.

2. Discuss non-invasive and invasive methods for diagnosing cardiac amyloidosis

3. Identify pitfalls of nuclear imaging tests to help reduce false readings

4. Discuss and analyze emerging amyloidosis treatments

5. Evaluate new diagnostic tools and their potential to improve early detection of the disease/subtypes

6. Discuss common challenges in diagnosis, treatment and long-term management of amyloidosis

Accreditation and Credit Designation

In support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences and Cooperman Barnabas Medical Center. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Symposium page 1
Symposium page 2
Faculty – Amyloidosis Symposium

Sabahat Bokhari, MD, FACC, FASNC, Professor of Medicine and Program Director of Advanced Cardiac Imaging Fellowship - Rutgers Robert Wood Johnson Medical School; Director of Advanced Cardiovascular Imaging – Robert Wood Johnson University Hospital; Director of Amyloidosis Center of Excellence

Partho Sengupta, MD, DM, FASE, FACC, Henry Rutgers Professor of Cardiology; Chief, Division of Cardiovascular Disease & Hypertension - Robert Wood Johnson Medical School; Chief of Cardiac Services - Robert Wood Johnson University Hospital

Yasmin Hamirani, MD, Associate Professor of Medicine - Rutgers Robert Wood Johnson Medical School; Director of Structural Imaging - Robert Wood Johnson University Hospital

Ruchika Bhargav, MD, Assistant Professor of Medicine - Rutgers Robert Wood Johnson Medical School

Michael Huang, DO, Assistant Professor of Medicine - Rutgers Robert Wood Johnson Medical School; Director of Critical Cardiovascular Unit - Robert Wood Johnson University Hospital

Billie Fyfe-Kirschner, MD, Professor of Pathology - Rutgers Robert Wood Johnson Medical School and Rutgers New Jersey Medical School; Interim Chair - Department of Pathology, Newark Beth Israel Medical Center

Mansi Shah, MD, Associate Professor of Medicine - Rutgers Cancer Institute; Core Faculty, Hematology-Oncology Fellowship Program - Rutgers Robert Wood Johnson Medical School; Clinical Director of Multiple Myeloma - Robert Wood Johnson University Hospital/Rutgers Cancer Institute

Shan Chen, MD, PhD, Associate Professor of Neurology; Director, Peripheral Neuropathy Program and GBS/CIDP Center of Excellence, Foundation International; Director, EMG Laboratory; Director, Spasticity Program; Co-Director, ALS Multi-Disciplinary Clinic and Center of Excellence of ALS Association -Rutgers Robert Wood Johnson Medical School

Chonyang Albert, MD, FACC, FHFSA, Assistant Professor of Medicine - Rutgers Robert Wood Johnson Medical School; Medical Director of LVAD and MCS - Robert Wood Johnson University Hospital

Panelists

Kameswari Maganti, MD, FACC, Professor of Medicine - Rutgers Robert Wood Johnson Medical School; Section Chief, Non-Invasive Cardiology and Director, Echocardiography, Robert Wood University Hospital

Maya Guglin, MD, PhD, FACC, Professor of Medicine - Rutgers Robert Wood Johnson Medical School; Section Chief, Advanced Heart Failure - Robert Wood University Hospital

Lance Berger, MD, FACC, Medical Director, Cardiovascular Program Development, Community Medical Center, Robert Wood Johnson Barnabas Health

For more information, visit the Amyloid Center of Excellence